PREVENTION OF MICROALBUMINURIA IN TYPE 2 DIABETES (ROADMAP TRIAL)

被引：4

作者：

Haller, H. ^{[1
]}

Ito, S. ^{[2
]}

Izzo, J. L. ^{[3
]}

Januszewicz, A. ^{[1
,4
]}

Katayama, S. ^{[5
]}

Menne, J. ^{[1
]}

Mimran, A. ^{[6
]}

Rabelink, T. J. ^{[7
]}

Ritz, E. ^{[8
]}

Ruilope, L. M. ^{[9
]}

Rump, L. C. ^{[10
]}

Viberti, G. ^{[11
]}

机构：

[1] Hannover Med Sch, D-3000 Hannover, Germany

[2] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan

[3] SUNY Buffalo, Buffalo, NY 14260 USA

[4] Inst Cardiol, Warsaw, Poland

[5] Saitama Med Sch, Iruma, Saitama, Japan

[6] Hosp Lapeyronie, Montpellier, France

[7] Leiden Univ, Med Ctr, Leiden, Netherlands

[8] Univ Heidelberg, Heidelberg, Germany

[9] Hosp 12 Octubre, E-28041 Madrid, Spain

[10] Univ Dusseldorf, Dusseldorf, Germany

[11] Metab Med, London, England

来源：

JOURNAL OF HYPERTENSION | 2010年 / 28卷

关键词：

D O I：

10.1097/01.hjh.0000378896.82588.5c

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：E233 / E233

页数：1

共 50 条

[1] Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial)
Haller, H.
Januszewicz, A.
Mimran, A.
Menne, J.
Rabelink, T.
Ritz, E.
Rump, L. C.
Ruilope, L. M.
Viberti, G. C.
EUROPEAN HEART JOURNAL, 2010, 31 : 321 - 321
[2] Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial)
Haller, H.
Ritz, E.
Ruilope, L.
Rabelink, T.
Viberti, G.
DIABETOLOGIA, 2010, 53 : S98 - S99
[3] The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Grassi, Guido
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (15) : 2421 - 2424
[4] Prevention of Microalbuminuria in Diabetes Mellitus: Results of the ROADMAP Trial
Grassi, Guido
Mancia, Giuseppe
CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 265 - 267
[5] Prevention of Microalbuminuria in Diabetes Mellitus: Results of the ROADMAP Trial
Guido Grassi
Giuseppe Mancia
Current Hypertension Reports, 2011, 13 : 265 - 267
[6] Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in Type 2 diabetes
Chatzikyrkou, Christos
Menne, Jan
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (09) : 1087 - 1092
[7] Randomized Olmesartan And Diabetes Microalbuminuria Prevention Study (ROADMAP)
Ritz, Eberhard
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (05): : 145 - 147
[8] Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
Menne, Jan
Izzo, Joseph L., Jr.
Ito, Sadayoshi
Januszewicz, Andrzej
Katayama, Shigehiro
Chatzykirkou, Christos
Mimran, Albert
Rabelink, Ton J.
Ritz, Eberhard
Ruilope, Luis M.
Rump, Lars C.
Viberti, Giancarlo
Haller, Hermann
JOURNAL OF HYPERTENSION, 2012, 30 (04) : 811 - 818
[9] Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Haller, Hermann
Ito, Sadayoshi
Izzo, Joseph L., Jr.
Januszewicz, Andrzej
Katayama, Shigehiro
Menne, Jan
Mimran, Albert
Rabelink, Ton J.
Ritz, Eberhard
Ruilope, Luis M.
Rump, Lars C.
Viberti, Giancarlo
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 907 - 917
[10] Prevention of microalbuminuria in type 2 diabetes: Millimeters or milligrams?
Glassock, Richard J.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (12): : 3276 - 3278

← 1 2 3 4 5 →